Peter Marks

yellow road to bright light
Biotech

FDA proposes new approval pathway for rare diseases

To be eligible for the process, the investigational drug must take aim at correcting or replacing the specific genetic defect underlying the disease.
Gabrielle Masson Sep 3, 2025 1:20pm
FDA
Favicon Fierce Pharma

FDA's acting CDER head heads for the exit: report

Jun 23, 2025 1:48pm
flat earth

FDA leadership 'decapitated,' former leader Janet Woodcock says

Apr 7, 2025 4:04pm
pave smooth road path clear pavement asphalt

FDA's new platform guidance aims to smooth regulatory encounters

May 30, 2024 7:30am
ASGCT conference

How Peter Marks plans to prevent '3 billion visits' to FDA

May 8, 2024 11:05am
Marks

Peter Marks says FDA ready to review novel cancer vaccines

Apr 3, 2024 2:39pm